Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$12.16 - $19.77 $147,136 - $239,217
-12,100 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$11.25 - $14.75 $136,125 - $178,475
12,100 New
12,100 $158,000
Q3 2019

Nov 14, 2019

SELL
$22.08 - $47.08 $2.85 Million - $6.08 Million
-129,091 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.67 - $35.0 $2.93 Million - $4.52 Million
129,091 New
129,091 $3.59 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.23B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.